These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 16045013

  • 1. [Effect of simvastatin on cardiac fibrosis in patients with essential hypertension].
    Zhang GG, Zhang SD.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):280-2. PubMed ID: 16045013
    [Abstract] [Full Text] [Related]

  • 2. [Plasma endothelin level in hypertensive patients receiving standard anti-hypertensive therapy with or without statins].
    Liu XH, Li YF, Lai CL, Ji YR, Zhao JQ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):800-3. PubMed ID: 20128377
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG, Rupp H, Maisch B.
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
    Zhu S, Liu Y, Wang L, Meng QH.
    Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
    [Abstract] [Full Text] [Related]

  • 7. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T, Tanaka T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M.
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [Abstract] [Full Text] [Related]

  • 8. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
    Demir M, Acartürk E, Inal T, Attila G, Dönmez Y, Avkaroğullari M, Cayli M.
    Cardiovasc Pathol; 2007 Aug; 16(2):69-74. PubMed ID: 17317538
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Evaluation on the effect of Benazepril for hypertension through postmarketing surveillance].
    Cao W, Li L, Hu Y, Zhan S, Li X, Li P, Wu T, Li J, Wang T.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):190-3. PubMed ID: 11860782
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of benazepril after failure of the first antihypertensive treatment].
    Francillon A, Heintzmann F, Serrurier D.
    Therapie; 1994 Jun; 49(2):95-9. PubMed ID: 7817356
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.